Clinical trial
Use of Prone Position Ventilation (PPV) in Danish Patients With COVID-19 Induced Severe Adult Respiratory Distress Syndrome (ARDS) Treated With Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO)
NCT05693051 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Prone Position Ventilation (PPV) in Danish Patients With COVID-19 Induced Severe Adult Respiratory Distress Syndrome (ARDS) Treated With Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO)
- Lead sponsor
- Rigshospitalet, Denmark
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2020
- Completion date
- November 1, 2022
- Enrollment
- 68 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
adverse event, ards, human, covid-19 acute respiratory distress syndrome, extracorporeal membrane oxygenation, prone position